Xeloda (Capecitabine)
Showing 1 - 25 of 1,514
Pancreas Cancer, Pancreas Adenocarcinoma Trial in Cleveland (Capecitabine)
Not yet recruiting
- Pancreas Cancer
- Pancreas Adenocarcinoma
-
Cleveland, OhioUniversity Hospitals Cleveland Medical Center, Seidman Cancer Ce
Oct 29, 2023
Gastrointestinal Cancer Trial (Capecitabine, Sacituzumab govetican)
Not yet recruiting
- Gastrointestinal Cancer
- Capecitabine
- Sacituzumab govetican
- (no location specified)
Oct 2, 2023
Triple Negative Breast Cancer, Residual Disease Trial (Tetrathiomolybdate, Capecitabine, Pembrolizumab)
Not yet recruiting
- Triple Negative Breast Cancer
- Residual Disease
- Tetrathiomolybdate
- +2 more
- (no location specified)
Nov 15, 2023
Metastatic Breast Cancer Trial in Birmingham (Capecitabine Pill)
Not yet recruiting
- Metastatic Breast Cancer
- Capecitabine Pill
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
Oct 23, 2023
Triple Negative Breast Tumors Trial (Pembrolizumab injection, Capecitabine tablets, Local radiotherapy)
Not yet recruiting
- Triple Negative Breast Neoplasms
- Pembrolizumab injection
- +2 more
- (no location specified)
Jul 25, 2023
Hormone Receptor-positive Breast Cancer Trial in Tampa (Cemiplimab, Capecitabine)
Recruiting
- Hormone Receptor-positive Breast Cancer
-
Tampa, FloridaMoffitt Cancer Center
Dec 30, 2022
Triple Negative Breast Cancer Trial in Guangzhou (Capecitabine, Tucidinostat)
Recruiting
- Triple Negative Breast Cancer
-
Guangzhou, Guangdong, ChinaSun-yat sen university cancer center
Nov 1, 2022
Breast Cancer Trial in Guangzhou (Capecitabine, Aromatase Inhibitor)
Active, not recruiting
- Breast Cancer
- Capecitabine
- Aromatase Inhibitor
-
Guangzhou, Guangdong, ChinaState Key Laboratory of Oncology in South China, Sun Yat-sen Uni
Jan 27, 2023
Gastric Cancer, Adjuvant Chemo, XO Trial in Seoul (Docetaxel and capecitabine and oxaliplatin, capecitabine and oxaliplatin)
Recruiting
- Gastric Cancer, Adjuvant Chemotherapy, XO
- Docetaxel and capecitabine and oxaliplatin
- capecitabine and oxaliplatin
-
Seoul, Korea, Republic ofAsan Medical Center
Dec 30, 2022
Colonic Tumors, Neoadjuvant Therapy, Immune Checkpoint Inhibitors Trial in Nanning (Tislelizumab, Oxaliplatin, Capecitabine)
Recruiting
- Colonic Neoplasms
- +2 more
- Tislelizumab
- +3 more
-
Nanning, Guangxi, ChinaThe First Affiliated Hospital of Guangxi Medical University
Nov 9, 2023
Cholangiocarcinoma, Intrahepatic Trial in Shanghai (Capecitabine, PD-1 Antibody(Tislelizumab))
Recruiting
- Cholangiocarcinoma, Intrahepatic
- Capecitabine
- PD-1 Antibody(Tislelizumab)
-
Shanghai, ChinaLulu@Huashan.Org.Cn
Aug 16, 2022
Gastroesophageal Junction Adenocarcinoma Trial in Shijiazhuang (Oxaliplatin; Capecitabine, Oxaliplatin; Capecitabine; concurrent
Completed
- Gastroesophageal Junction Adenocarcinoma
- Oxaliplatin; Capecitabine
- Oxaliplatin; Capecitabine; concurrent radiotherapy
-
Shijiazhuang, Hebei, ChinaDepartment of General Surgery
Feb 4, 2022
Colo-rectal Cancer, Metastatic Cancer Trial in Besançon, Dijon, Montbéliard (Regorafenib, Cyclophosphamide, Capecitabine)
Active, not recruiting
- Colo-rectal Cancer
- Metastatic Cancer
- Regorafenib
- +3 more
-
Besançon, France
- +2 more
Jan 24, 2023
Capecitabine Versus S-1 as Adjuvant Therapy in Biliary Tract
Recruiting
- Biliary Tract Neoplasms
- +3 more
-
Shanghai, ChinaHuashan hospital
Aug 16, 2022
Metastatic Pancreatic Adenocarcinoma Trial (Ivaltinostat, Capecitabine)
Not yet recruiting
- Metastatic Pancreatic Adenocarcinoma
- (no location specified)
Feb 10, 2022
Early Low Rectal Cancer Trial in Shanghai (PD-1 antibody, Capecitabine, Oxaliplatin)
Recruiting
- Early Low Rectal Cancer
- PD-1 antibody
- +3 more
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Jan 9, 2023
Adenocarcinoma, Pancreatic Tumors, Tumor, Glandular Trial in Baltimore (Nab-paclitaxel, Gemcitabine, Capecitabine)
Recruiting
- Adenocarcinoma
- +9 more
- Nab-paclitaxel
- +4 more
-
Baltimore, MarylandSidney Kimmel Comprehensive Cancer Center
Mar 15, 2022
Locally Advanced Colon Cancer Trial (Serplulimab, short-term radiotherapy, Oxaliplatin)
Not yet recruiting
- Locally Advanced Colon Cancer
- Serplulimab
- +3 more
- (no location specified)
Feb 16, 2023
Rectal Adenocarcinoma Trial in Tampa (Capecitabine, Radiation Therapy, FOLFOX regimen)
Recruiting
- Rectal Adenocarcinoma
- Capecitabine
- +2 more
-
Tampa, FloridaMoffitt Cancer Center
Jan 24, 2023
Radiotherapy, PD-1 Inhibitor, Capecitabine Trial in Zhuhai (SBRT radiotherapy + Conventionally fractionated radiotherapy, PD-1
Recruiting
- Radiotherapy
- +3 more
- SBRT radiotherapy + Conventionally fractionated radiotherapy
- +2 more
-
Zhuhai, Guangdong, ChinaFifth Affilliated Hospital of Sun Yat-sen University
Apr 13, 2022
Head and Neck Squamous Cell Carcinoma Trial in Norfolk, Omaha (Capecitabine, Docetaxel, Quality-of-Life Assessment)
Terminated
- Head and Neck Squamous Cell Carcinoma
- Capecitabine
- +3 more
-
Norfolk, Nebraska
- +2 more
Aug 10, 2022
Pancreatic Cancer Trial in Pittsburgh (Gemcitabine, Capecitabine, Stereotactic Body Radiation Therapy (SBRT))
Completed
- Pancreatic Cancer
- Gemcitabine
- +2 more
-
Pittsburgh, PennsylvaniaUPMC Cancer Centers
Feb 10, 2022
Gastroesophageal Junction (GEJ) Adenocarcinoma Trial in Beijing (Q-1802 Injection,Oxaliplatin Injection,Capecitabine)
Recruiting
- Gastroesophageal Junction (GEJ) Adenocarcinoma
- Q-1802 Injection,Oxaliplatin Injection,Capecitabine
-
Beijing, Beijing, ChinaBeijing cancer hospical
Jul 27, 2023
Hematopoietic and Lymphoid System Tumor, Metastatic Colorectal Carcinoma, Metastatic Malignant Solid Tumor Trial (BET
Not yet recruiting
- Hematopoietic and Lymphoid System Neoplasm
- +5 more
- BET Bromodomain Inhibitor ZEN-3694
- +6 more
- (no location specified)
Apr 6, 2023